Редактирование:
Aging genes 60-69
(раздел)
Перейти к навигации
Перейти к поиску
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
==LMNA== * {{medline-title |title=Metformin alters peripheral blood mononuclear cells (PBMC) senescence biomarkers gene expression in type 2 diabetic patients. |date=01.2021 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33187870 |full-text-url=https://sci-hub.do/10.1016/j.jdiacomp.2020.107758 }} * {{medline-title |title=Protein structural and mechanistic basis of progeroid laminopathies. |date=16.08.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32799420 |full-text-url=https://sci-hub.do/10.1111/febs.15526 }} * {{medline-title |title=Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS). |date=30.06.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32539085 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329345 }} * {{medline-title |title=Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells. |date=12.05.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32408587 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290406 }} * {{medline-title |title=The JAK1/2 inhibitor ruxolitinib delays premature aging phenotypes. |date=04.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32196928 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189991 }} * {{medline-title |title=Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson-Gilford progeria syndrome. |date=04.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32048129 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205988 }} * {{medline-title |title=Long term breeding of the Lmna G609G progeric mouse: Characterization of homozygous and heterozygous models. |date=02.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31794853 |full-text-url=https://sci-hub.do/10.1016/j.exger.2019.110784 }} * {{medline-title |title=Epigenetic signatures of Werner syndrome occur early in life and are distinct from normal epigenetic aging processes. |date=10.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31259468 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718529 }} * {{medline-title |title=Transient introduction of human telomerase mRNA improves hallmarks of progeria cells. |date=08.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31152494 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612639 }} * {{medline-title |title=A humanized yeast system to analyze cleavage of prelamin A by [[ZMPSTE24]]. |date=15.03.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30625386 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401292 }} * {{medline-title |title=Impaired immune surveillance accelerates accumulation of senescent cells and aging. |date=21.12.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30575733 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303397 }} * {{medline-title |title=Endothelial progerin expression causes cardiovascular pathology through an impaired mechanoresponse. |date=01.02.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30422822 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355303 }} * {{medline-title |title=Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes. |date=12.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30216637 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260922 }} * {{medline-title |title=Altered modulation of lamin A/C-[[HDAC2]] interaction and p21 expression during oxidative stress response in HGPS. |date=10.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30109767 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156291 }} * {{medline-title |title=Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome. |date=09.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30037605 |full-text-url=https://sci-hub.do/10.1016/j.mehy.2018.06.029 }} * {{medline-title |title=Proteomic changes during adult stage in pre-optic, hypothalamus, hippocampus and pituitary regions of female rat brain following neonatal exposure to estradiol-17β. |date=15.09.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29777688 |full-text-url=https://sci-hub.do/10.1016/j.ygcen.2018.05.005 }} * {{medline-title |title=RECQ helicase disease and related progeroid syndromes: RECQ2018 meeting. |date=07.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29752965 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217841 }} * {{medline-title |title=Upregulation of the aging related [[LMNA]] splice variant progerin in dilated cardiomyopathy. |date=2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29702688 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922532 }} * {{medline-title |title=Increasing autophagy and blocking Nrf2 suppress laminopathy-induced age-dependent cardiac dysfunction and shortened lifespan. |date=06.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29575479 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946079 }} * {{medline-title |title=Lipodystrophic syndromes due to [[LMNA]] mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives. |date=01.01.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29578370 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973242 }} * {{medline-title |title=Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome. |date=04.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29476423 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876188 }} * {{medline-title |title=Mandibuloacral dysplasia: A premature ageing disease with aspects of physiological ageing. |date=03.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29208544 |full-text-url=https://sci-hub.do/10.1016/j.arr.2017.12.001 }} * {{medline-title |title=Hutchinson-Gilford Progeria Syndrome: A Premature Aging Disease. |date=05.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28660486 |full-text-url=https://sci-hub.do/10.1007/s12035-017-0610-7 }} * {{medline-title |title=Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome. |date=15.07.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28483909 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492170 }} * {{medline-title |title=Physiological and Pathological Aging Affects Chromatin Dynamics, Structure and Function at the Nuclear Edge. |date=2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27602048 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993774 }} * {{medline-title |title=Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome. |date=12.07.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27400896 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943677 }} * {{medline-title |title=Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by [[LMNA]] gene mutations. |date=01.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27374873 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5195863 }} * {{medline-title |title=Progeria and the early aging in children: a case report. |date=17.02.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27267192 }} * {{medline-title |title=A Heterozygous [[ZMPSTE24]] Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated Cardiomyopathy. |date=25.04.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27120622 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931670 }} * {{medline-title |title=Understanding Vascular Diseases: Lessons From Premature Aging Syndromes. |date=05.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26948039 |full-text-url=https://sci-hub.do/10.1016/j.cjca.2015.12.003 }} * {{medline-title |title=Molecular insights into the premature aging disease progeria. |date=04.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26847180 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796323 }} * {{medline-title |title=[[LMNA]] mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of [[ZMPSTE24]] downregulation. |date=02.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26724531 |full-text-url=https://sci-hub.do/10.1016/j.atherosclerosis.2015.12.012 }} * {{medline-title |title=Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria. |date=04.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26663466 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783354 }} * {{medline-title |title=Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery. |date=11.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26474742 |full-text-url=https://sci-hub.do/10.1016/j.arr.2015.10.002 }} * {{medline-title |title=All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype. |date=06.10.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26359359 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745772 }} * {{medline-title |title=New look at the role of progerin in skin aging. |date=03.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26327889 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440198 }} * {{medline-title |title=Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria. |date=27.08.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26312502 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565980 }} * {{medline-title |title=Overexpression of Lamin B Receptor Results in Impaired Skin Differentiation. |date=2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26053873 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459694 }} * {{medline-title |title=Sustained accumulation of prelamin A and depletion of lamin A/C both cause oxidative stress and mitochondrial dysfunction but induce different cell fates. |date=2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25996284 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615646 }} * {{medline-title |title=Age-Related Lipid Metabolic Signature in Human [[LMNA]]-Lipodystrophic Stem Cell-Derived Adipocytes. |date=07.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25961135 |full-text-url=https://sci-hub.do/10.1210/jc.2014-4528 }} * {{medline-title |title=Transgene silencing of the Hutchinson-Gilford progeria syndrome mutation results in a reversible bone phenotype, whereas resveratrol treatment does not show overall beneficial effects. |date=08.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25877214 |full-text-url=https://sci-hub.do/10.1096/fj.14-269217 }} * {{medline-title |title=Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts. |date=02.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25510262 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326906 }} * {{medline-title |title=Expression of progerin in aging mouse brains reveals structural nuclear abnormalities without detectible significant alterations in gene expression, hippocampal stem cells or behavior. |date=01.03.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25343989 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321440 }} * {{medline-title |title=Accumulation of prelamin A compromises NF-κB-regulated B-lymphopoiesis in a progeria mouse model. |date=2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24764515 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922919 }} * {{medline-title |title=Prelamin A accumulation and stress conditions induce impaired Oct-1 activity and autophagy in prematurely aged human mesenchymal stem cell. |date=04.2014 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24753226 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032794 }} * {{medline-title |title=Antagonistic functions of [[LMNA]] isoforms in energy expenditure and lifespan. |date=05.2014 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24639560 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210101 }} * {{medline-title |title=Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review. |date=2014 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24603298 |full-text-url=https://sci-hub.do/10.1159/000357206 }} * {{medline-title |title=RB and lamins in cell cycle regulation and aging. |date=2014 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24563346 |full-text-url=https://sci-hub.do/10.1007/978-1-4899-8032-8_6 }} * {{medline-title |title=Search and insights into novel genetic alterations leading to classical and atypical Werner syndrome. |date=2014 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24401204 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997596 }} * {{medline-title |title=Mapping disease-related missense mutations in the immunoglobulin-like fold domain of lamin A/C reveals novel genotype-phenotype associations for laminopathies. |date=06.2014 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24375749 |full-text-url=https://sci-hub.do/10.1002/prot.24465 }} * {{medline-title |title=Investigation of age-related changes in [[LMNA]] splicing and expression of progerin in human skeletal muscles. |date=2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24294364 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843258 }} * {{medline-title |title=Investigation of splicing changes and post-translational processing of [[LMNA]] in sporadic inclusion body myositis. |date=2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24040437 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759479 }} * {{medline-title |title=Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture. |date=08.10.2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23969228 |full-text-url=https://sci-hub.do/10.1016/j.jprot.2013.08.008 }} * {{medline-title |title=The contrasting roles of lamin B1 in cellular aging and human disease. |date=07-08.2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23873483 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810336 }} * {{medline-title |title=Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model. |date=2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23695662 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674265 }} * {{medline-title |title=Hutchinson-Gilford progeria syndrome through the lens of transcription. |date=08.2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23496208 |full-text-url=https://sci-hub.do/10.1111/acel.12070 }} * {{medline-title |title=Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations. |date=08.2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23450819 |full-text-url=https://sci-hub.do/10.1002/mus.23827 }} * {{medline-title |title=Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells. |date=11.2012 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23362510 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560431 }} * {{medline-title |title=Aberrant DNA methylation profiles in the premature aging disorders Hutchinson-Gilford Progeria and Werner syndrome. |date=01.2013 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23257959 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549877 }} * {{medline-title |title=Resveratrol rescues [[SIRT1]]-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. |date=05.12.2012 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23217256 |full-text-url=https://sci-hub.do/10.1016/j.cmet.2012.11.007 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Навигация
Персональные инструменты
Вы не представились системе
Обсуждение
Вклад
Создать учётную запись
Войти
Пространства имён
Статья
Обсуждение
русский
Просмотры
Читать
Править
История
Ещё
Навигация
Начало
Свежие правки
Случайная страница
Инструменты
Ссылки сюда
Связанные правки
Служебные страницы
Сведения о странице
Дополнительно
Как редактировать
Вики-разметка
Telegram
Вконтакте
backup